Chem. J. Chinese Universities

• 研究论文 • Previous Articles     Next Articles

Radioiodination and Biodistribution of PEGy Lated YP13 Polypeptide

SUN Li-Yan, CHU Tai-Wei*, WANG Yi, WANG Xiang-Yun   

  1. Bejing National Laboratory for Molecular Sciences(BNLMS), Department of Applied Chemistry, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China
  • Received:2006-07-03 Revised:1900-01-01 Online:2007-04-10 Published:2007-04-10
  • Contact: CHU Tai-Wei

Abstract: A dodeca-peptide SVSVGMLPSHAP that targets human CL-187 tumor was identified in vivo by phage display technology. In order to evaluate the potency of YP13 as the imaging agent for diagnosis of tumor and to be easily radioiodinated, peptide YSVSVGMLPSHAP(YP13) with tyramine being added to the N-terminal was synthesized and chemically modified by conjugation with a low molecular weight monomethoxy polyethylene glycol(mPEG, Mw=5000). YP13, mPEG-YP13 and YR13(a nonspecific random 13 peptide as a control peptide) were labeled with 131I via Iodogen method. The labeled complex 131I-YP13, 131I-mPEG-YP13 and 131I-YR13 were isolated and purified by RP-HPLC. The radiochemical purity was estimated to be better than 95%. The RP-HPLC analysis of the supernatant of 131I-YP13 and 131I-mPEG-YP13 in serum collected for 60 min after injection shows that 131I-mPEG-YP13 in vivo was far more stable than 131I-YP13. The biodistribution of 131I-YP13, 131I-mPEG-YP13 and the control peptide 131I-YR13 in mice bearing human colon cancinoma was investigated. The experimental results indicate that there was higher uptake of 131I-YP13 and 131I-mPEG-YP13 in tumor than that of control peptide YR13 at 1 h and 2 h. The ratios of tumor to blood for 131I-mPEG-YP13 and 131I-YP13 increased as time prolonging. The longer serum half-life of mPEG-YP13 improved the uptake in tumor. Therefore, it can be expected that the radioiodinated YP13 and PEGylated YP13 may be a potential tumor-imaging agent.

Key words: Peptide, Phage display technology, PEG , 131I Radioiodination, Biodistribution

CLC Number: 

TrendMD: